Mersana Therapeutics, Inc. (NASDAQ:MRSN) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The consensus estimated revenue numbers ...

MRSN opened at $0.51 on Wednesday. The stock’s fifty day simple moving average is $0.82 and its 200 day simple moving average is $1.56. Mersana Therapeutics, Inc. has a 1-year low of $0.46 and a ...

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2024 Earnings Call Transcript March 3, 2025 Mersana Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.16.

Mersana Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.16. Operator: Good morning, and welcome to Mersana Therapeutics Fourth Quarter and Year End ...

Net Loss: $14.1 million for Q4 2024, compared to $19.5 million in Q4 2023. Mersana Therapeutics Inc (NASDAQ:MRSN) reported positive initial clinical data for its lead dolasynthen ADC, Emi-Le ...

Mersana Therapeutics stock opened at $0.48 on Monday. The firm has a market cap of $59.30 million, a price-to-earnings ratio of -0.79 and a beta of 1.39. Mersana Therapeutics has a 1 year low of ...

At the close in NYSE, the Dow... H.C. Wainwright analyst Edward White maintained a Buy rating on Mersana Therapeutics (NASDAQ:MRSN) Inc on Friday, setting a price target of $28, which is ...

Good morning, and welcome to Mersana Therapeutics Fourth Quarter and Year End 2024 Conference Call. Currently all participants are in a listen-only mode. There will be a question-and-answer ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Mersana Therapeutics Inc (NASDAQ:MRSN) is set to release its Q4 2024 earnings on March 3, 2025. The consensus estimate for Q4 2024 revenue is $7.67 million, and the earnings are expected to come ...

Mersana Therapeutics Inc. (MRSN)股价已跌至52周新低，仅报0.49美元，市值降至约6000万美元。该公司股价一年内暴跌90.9%。根据InvestingPro数据显示，尽管公司现金储备仍高于债务，但可用资金正在快速消耗。投资者一直担忧地看着MRSN股价持续下跌，触及这一新低点 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...